Geode Capital Management’s Vor Biopharma VOR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $706K | Sell |
435,560
-2,450
| -0.6% | -$3.97K | ﹤0.01% | 3444 |
|
|
2025
Q1 | $314K | Buy |
438,010
+15,867
| +4% | +$11.4K | ﹤0.01% | 3705 |
|
|
2024
Q4 | $469K | Hold |
422,143
| – | – | ﹤0.01% | 3618 |
|
|
2024
Q3 | $296K | Sell |
422,143
-2,689
| -0.6% | -$1.88K | ﹤0.01% | 3772 |
|
|
2024
Q2 | $425K | Sell |
424,832
-416,376
| -49% | -$416K | ﹤0.01% | 3627 |
|
|
2024
Q1 | $1.99M | Buy |
841,208
+47,145
| +6% | +$112K | ﹤0.01% | 3110 |
|
|
2023
Q4 | $1.79M | Buy |
794,063
+37,711
| +5% | +$84.9K | ﹤0.01% | 3146 |
|
|
2023
Q3 | $1.6M | Buy |
756,352
+33,947
| +5% | +$72K | ﹤0.01% | 3151 |
|
|
2023
Q2 | $2.23M | Buy |
722,405
+406,458
| +129% | +$1.26M | ﹤0.01% | 3076 |
|
|
2023
Q1 | $1.7M | Buy |
315,947
+149,182
| +89% | +$803K | ﹤0.01% | 3103 |
|
|
2022
Q4 | $1.11M | Buy |
166,765
+31,167
| +23% | +$207K | ﹤0.01% | 3297 |
|
|
2022
Q3 | $539K | Buy |
135,598
+28,223
| +26% | +$112K | ﹤0.01% | 3684 |
|
|
2022
Q2 | $533K | Sell |
107,375
-149,625
| -58% | -$743K | ﹤0.01% | 3727 |
|
|
2022
Q1 | $1.55M | Buy |
257,000
+6,225
| +2% | +$37.6K | ﹤0.01% | 3383 |
|
|
2021
Q4 | $2.91M | Sell |
250,775
-21,162
| -8% | -$246K | ﹤0.01% | 3182 |
|
|
2021
Q3 | $4.26M | Buy |
271,937
+77,211
| +40% | +$1.21M | ﹤0.01% | 3003 |
|
|
2021
Q2 | $3.63M | Buy |
194,726
+6,511
| +3% | +$121K | ﹤0.01% | 3081 |
|
|
2021
Q1 | $8.11M | Buy |
+188,215
| New | +$8.11M | ﹤0.01% | 2505 |
|